Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Media and Games Invest SE | M8G | Nov 14, 2024 | 3.96 | -2.22 |
Mediaco Holding Inc. - Class A | 3WX | Nov 14, 2024 | 1.04 | -0.95 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | Nov 14, 2024 | 0.15 | +0.67 |
Median Technologies | 4ZG | Nov 14, 2024 | 4.20 | +5.40 |
Mediaseek Inc. | 6WJ | Nov 14, 2024 | 1.60 | 0.00 |
Medibank Private Limited | MPV | Nov 14, 2024 | 2.22 | -0.89 |
Medical Facilities Corp | 31F | Nov 14, 2024 | 10.90 | +7.92 |
Medical Properties Trust Inc | M3P | Nov 14, 2024 | 4.01 | -1.44 |
Mediclin AG | MED | Nov 14, 2024 | 2.40 | 0.00 |
Medicover B | 5M0B | Nov 14, 2024 | 15.16 | +0.40 |
Medicure Inc | NGQ1 | Nov 14, 2024 | 0.54 | -5.31 |
MEDICUS PHARMA LTD. | N46 | Nov 14, 2024 | 0.57 | 0.00 |
MEDICUS PHARMA LTD. | N460 | Nov 14, 2024 | 3.96 | 0.00 |
MEDIFAST INC | MDF | Nov 14, 2024 | 16.78 | -6.31 |
Medigene AG | MDG1 | Nov 14, 2024 | 1.64 | +2.63 |
Medimi | 79T | Nov 14, 2024 | 0.00 | 0.00 |
Medincell S.A. | MEB | Nov 14, 2024 | 17.70 | -0.34 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | Nov 14, 2024 | 14.20 | +0.71 |
Mediobanca SpA | ME9 | Nov 14, 2024 | 14.31 | +0.74 |
Medion AG | MDN | Nov 14, 2024 | 14.30 | +0.70 |
Medios AG | ILM1 | Nov 14, 2024 | 14.70 | -0.94 |
Medipal Holdings Corporation | 59Z | Nov 14, 2024 | 14.60 | -0.68 |
Medipharm Labs Corp | MLZ | Nov 14, 2024 | 0.04 | -7.86 |
Medistim | MD1 | Nov 14, 2024 | 11.15 | -4.70 |
MEDIVIR AB | MVR0 | Nov 14, 2024 | 0.22 | +1.39 |
MediWound Ltd. - Ordinary Shares | M8W | Nov 14, 2024 | 15.50 | -1.27 |
Medley Inc. | 3YV | Nov 14, 2024 | 21.80 | -2.68 |
Medmira Inc | 47M | Nov 14, 2024 | 0.05 | -6.12 |
Mednax, Inc. | PDC | Nov 14, 2024 | 14.30 | -0.69 |
Medpace Holdings, Inc. | 01P | Nov 14, 2024 | 317.90 | -7.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.